PK/PD strategy. Article Swipe
Related Concepts
Le Bihan Amélie
,
Kanter Ruben de
,
Íñigo Angulo‐Barturen
,
Binkert Christoph
,
Boss Christoph
,
Reto Brun
,
Brunner Ralf
,
Buchmann Stephan
,
Burrows Jeremy
,
Joshua D. Koen
,
Delves Michael
,
Ewerling Sonja
,
Ferrer Santiago
,
Christoph Fischli
,
Gamo–Benito Francisco Javier
,
F. Gnädig Nina
,
Heidmann Bibia
,
Belén Jiménez-Díaz María
,
Didier Leroy
,
Martínez Maria Santos
,
Meyer Solange
,
Moehrle Joerg J.
,
Ng Caroline L.
,
Rintis Noviyanti
,
Andrea Ruecker
,
Sanz Laura María
,
W. Sauerwein Robert
,
Scheurer Christian
,
Schleiferboeck Sarah
,
Sinden Robert
,
Snyder Christopher
,
Straimer Judith
,
Grennady Wirjanata
,
Marfurt Jutta
,
N. Price Ric
,
Weller Thomas
,
Fischli Walter
,
Fidock David A.
,
Martine Clozel
,
Sergio Wittlin
·
YOU?
·
· 2016
· Open Access
·
· DOI: https://doi.org/10.1371/journal.pmed.1002138.g009
· OA: W2529354290
YOU?
·
· 2016
· Open Access
·
· DOI: https://doi.org/10.1371/journal.pmed.1002138.g009
· OA: W2529354290
<p>Workflow of PK and PD modeling approach towards human efficacious dose prediction. Abbreviations: maximum observed plasma concentration (C<sub>max</sub>) and, area under the concentration versus time curve (AUC).</p>
Related Topics
Finding more related topics…